Recursion Pharmaceuticals

Roche, Recursion advance first AI-discovered drug target

Roche and its subsidiary Genentech have advanced the first neuroscience drug target to emerge from their artificial intelligence partnership with Recursion Pharmaceuticals, moving it into an early discovery program in what both companies describe as a proof point for AI-driven…